Home › Trial NCT07489066
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Trial IDNCT07489066
- StatusRecruiting
- PhasePhase 2
- Study typeInterventional
- SponsorPfizer
- Enrollment120
- Start date2026-06-30
- ConditionsCarcinoma · Non-Small-Cell Lung · Lung Cancer (NSCLC) · Lung Neoplasms · Carcinoma, Non-Small-Cell Lung (NSCLC) · Lung Disease
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.